Resolution of Unilateral Dome-Shaped Macula With Serous Detachment After Treatment of Topical Carbonic Anhydrase Inhibitors

Ophthalmic Surg Lasers Imaging Retina. 2019 Aug 1;50(8):e218-e221. doi: 10.3928/23258160-20190806-16.

Abstract

Dome-shaped macula (DSM) is a morphological feature outlined through the use of optical coherence tomography and characterized by an inward or anterior deviation of the macula with respect to chorioretinal concavity. Currently, there is no validated therapy for serous retinal detachment secondary to DSM. The authors report a case of childhood unilateral DSM in a hyperopic eye with normal axial length that was complicated with subretinal fluid (SRF). Topical carbonic anhydrase inhibitors may be an acceptable and safer option for patients presented with nonresolving SRF associated with DSM. Further randomized controlled trials are necessary to confirm the efficacy of this therapeutic approach. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:e218-e221.].

Publication types

  • Case Reports

MeSH terms

  • Carbonic Anhydrase Inhibitors / administration & dosage*
  • Child
  • Female
  • Humans
  • Macula Lutea / abnormalities*
  • Macular Edema / drug therapy*
  • Retinal Detachment / drug therapy*
  • Subretinal Fluid / drug effects*
  • Treatment Outcome

Substances

  • Carbonic Anhydrase Inhibitors